Filter
4110
Text search:
drug
strategy
Featured
Recommendations
369
New Publications
1146
Language
Document type
No document type
2428
Studies & Reports
687
Guidelines
511
Manuals
175
Strategic & Response Plan
174
Fact sheets
50
Training Material
49
Situation Updates
18
Infographics
11
Resource Platforms
5
Brochures
2
Countries / Regions
India
205
Global
162
Kenya
131
Uganda
106
South Africa
104
Ethiopia
102
Western and Central Europe
89
Nigeria
86
Nepal
80
Liberia
76
Sierra Leone
71
Malawi
71
Latin America and the Carribbean
71
Tanzania
70
Zambia
67
Myanmar / Burma
66
Africa
66
Bangladesh
58
Ghana
57
Rwanda
50
Namibia
47
Eastern Europe
44
Philippines
37
Ukraine
37
Asia
37
Cambodia
36
South–East Asia Region
33
Zimbabwe
31
Lesotho
28
Indonesia
24
Botswana
24
Russia
21
Syria
19
Mozambique
18
Colombia
18
Congo, Democratic Republic of
17
Senegal
16
Brazil
14
East and Southern Africa
14
Burkina Faso
13
Eswatini/ Swaziland
13
West and Central Africa
13
South Sudan
11
Thailand
11
Middle East and North Africa
11
Eastern Europe and Central Asia
10
Albania
10
Cameroon
9
Pakistan
9
Sudan
9
Venezuela
9
Vietnam
9
Guinea
8
Haiti
8
Western Pacific Region
8
Tajikistan
8
Georgia
8
USA
7
Germany
7
Peru
7
Laos
7
Afghanistan
6
China
6
Argentina
6
Sri Lanka
5
North America
5
Jordan
4
Benin
4
North Macedonia
4
El Salvador
4
Yemen
4
Timor Leste/ East Timor
4
Moldova
4
Iran
4
Somalia
3
Iraq
3
Lebanon
3
Turkey
3
Central African Republic
3
Honduras
3
Bolivia
3
Mexico
3
Paraguay
3
Bhutan
3
Jamaica
3
Mali
2
Morocco
2
Papua New Guinea
2
Switzerland
2
Hungary
2
Guatemala
2
Madagascar
2
Nicaragua
2
Southern Africa
2
Estonia
2
Uzbekistan
2
Kyrgyzstan
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Chad
1
Gambia
1
Ireland
1
Dominican Republic
1
Austria
1
Serbia
1
Greece
1
Libya
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Kazakhstan
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1662
Clinical Guidelines
341
Public Health
232
Women & Child Health
138
Key Resources
119
Capacity Building
57
Pharmacy & Technologies
40
Annual Report MEDBOX
1
Toolboxes
HIV
499
TB
435
Mental Health
299
AMR
204
NTDs
202
COVID-19
152
NCDs
94
Malaria
92
Pharmacy
89
Caregiver
66
Planetary Health
55
Rapid Response
53
Ebola & Marburg
52
Global Health Education
46
Disability
45
Conflict
45
Refugee
40
Health Financing Toolbox
39
2.0 Rapid Response
23
Polio
21
Cholera
14
Natural Hazards
13
Specific Hazards
11
Zika
10
Social Ethics
7
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
...
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, stren
...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact
...
Framework for implementation.
The END TB Strategy.
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not b
...
In November 2022, WHO launched a strategy to address antimalarial drug resistance in Africa, emphasizing the need for stronger surveillance. While regional monitoring networks have been active in ot
...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty
...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv
...
Countries, partners, and donors are committed to the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more than funding; it requires health personnel with the
right mix of skills, and well supported and managed health systems. Mass
...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of re
...
Soil-transmitted helminths (STH) affect 1.45 billion people worldwide, and high intensity infections are associated with anemia, undernutrition and impaired cognition, particularly among children. Mathematical models suggest it may be possible to interrupt the transmission of STH in a community by e
...
Front. Public Health 9:622809
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel
...
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monito
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainsta
...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi
...
